Peptides Save Lives and Eyes

Peptides Are Life‑Saving and Eye‑Saving: Which Peptides Help With Dry Eye Disease? 

 By Sandra Lora Cremers, MD, FACS 

Peptides save lives. Your body is filled with peptides. They regulate your hormones, repair your tissues, fight infections, calm inflammation, and even help determine how your eyes heal after injury or surgery. But what exactly is a peptide — and why are peptides becoming some of the most powerful tools in modern medicine, including the treatment of Dry Eye Disease? This topic will also be featured on The Eye Show podcast, where I’ll break down the science in a simple, practical way for patients and clinicians.

 

Biologic Therapy	Representative Peptides / Factors	Functional Role
PRP eye drops	PDGF, TGF‑β, VEGF, EGF, IGF‑1, fibrin peptides	Epithelial healing, anti-apoptotic, remodeling
Autologous serum	EGF, TGF‑β, IGF‑1, albumin peptides	Tear-film mimicry, epithelial nutrition
CBS eye drops	EGF, TGF‑β, NGF, BDNF, IGF‑1	Neurotrophic support, epithelial healing
Amniotic membrane	ECM peptides, HC‑HA/PTX3	Anti-inflammatory, anti-fibrotic, stem-cell support

Peptide / Group	Main Domain	Key Actions	Dry Eye Relevance
Thymosin β4 (Tβ4)	DED / wound healing	Migration, anti-inflammatory, anti-apoptotic	Yes – studied in DED trials
YP‑P10	DED	Synthetic anti-inflammatory peptide	Yes – investigational
Substance P + IGF‑1	Neurotrophic	Nerve healing, epithelial closure	Indirect – NK / severe OSD
NGF-derived peptides	Neurotrophic	Nerve regeneration	Yes – especially NK
AM ECM peptides	DED / OSD	Anti-inflammatory, anti-scarring	Yes – via AM
GLP‑1 analogs	Longevity / metabolic	↓ inflammation, metabolic control	Indirect
GHRH / GH peptides	Longevity	Anabolism, repair	Indirect
BPC‑157	Regenerative	Angiogenesis, tendon/gut healing	No direct DED data
GHK‑Cu	Skin / repair	Collagen, antioxidant	No direct DED data
Food bioactive peptides	Cancer / CV	ACE inhibition, antioxidant	Indirect

What Exactly Is a Peptide?

To understand why peptides are revolutionizing medicine, you need to understand what they are at the molecular level.

A peptide is a short chain of amino acids linked together by peptide bonds. Amino acids are the building blocks of life — there are 20 standard amino acids that combine in different sequences to create every protein and peptide in your body. When fewer than about 50 amino acids link together, we call that chain a peptide. When the chain is longer, we call it a protein.

Think of it like language:

• Amino acids are letters

• Peptides are words

• Proteins are sentences

A peptide is a precisely ordered “word” that your body reads and acts upon.

How Do Peptides Work?

Every cell in your body has receptors on its surface — think of them as locks. Peptides are the keys. When a specific peptide binds to its matching receptor, it triggers a cascade of signals inside the cell. This can tell the cell to:

• Grow

• Divide

• Produce a specific substance

• Reduce inflammation

• Release a hormone

• Migrate to an injury site

• Or even self‑destruct (in the case of cancer cells receiving the right signal)

This is why peptides are so powerful: they deliver precise instructions to the exact cells that need them.

Why Peptides Are Transforming Medicine

Peptides are uniquely powerful because they combine the precision of biologics with the safety of natural molecules your body already understands.

Why peptides matter:

1. High specificity — they bind to their target receptors with remarkable precision

2. Low toxicity — your body can break them down naturally

3. Biodegradability — they do not accumulate in tissues

4. Minimal immunogenicity — less likely to trigger immune reactions

5. Versatility — they can be engineered to target almost any pathway

6. Natural compatibility — your body already makes thousands of peptides (insulin, GLP‑1, oxytocin, endorphins)

Modern pharmaceutical engineering has solved their old limitations.

Techniques like PEGylation, cyclization, D‑amino acid substitution, liposomal delivery, and advanced oral formulations (e.g., oral GLP‑1 agonists) now allow peptides to last longer, work better, and be taken more conveniently.

The numbers tell the story:

• 87,600+ peptide‑therapeutic publications on PubMed

• 140+ peptide therapeutics in clinical trials

• 29 FDA‑approved peptide‑based anticancer drugs

• 200+ peptide‑vaccine clinical trials for cancer in 2023–2024 alone

This is not fringe science.

This is mainstream medicine accelerating at full speed — and it has the potential to save your life and save your eyes.

Peptides and the Eye: Why They Matter for Dry Eye Disease

The ocular surface is one of the most peptide‑responsive tissues in the body. Corneal epithelial cells, limbal stem cells, immune cells, and corneal nerves all rely on peptide‑based signaling to heal, regenerate, and regulate inflammation.

This is why many of the most effective treatments for severe Dry Eye Disease are peptide‑rich biologics, including:

• Platelet‑Rich Plasma (PRP) eye drops

• Autologous Serum (AS) eye drops

• Cord Blood Serum (CBS) eye drops

• Amniotic Membrane (AM) grafts or drops

These therapies naturally contain growth factors and peptide fragments that mimic the healing environment of healthy tears.

Which Peptides Are Most Important for Dry Eye Disease?

Several peptides have been directly studied for Dry Eye Disease and ocular surface healing:

1. Thymosin β4 (Tβ4)

• Promotes corneal epithelial migration

• Reduces inflammation

• Protects cells from apoptosis

• Studied in Phase II trials for Dry Eye Disease

2. YP‑P10 (Yuyu Pharma)

• A synthetic anti‑inflammatory peptide

• Currently in clinical trials for DED (ICECAP‑1)

3. Substance P + IGF‑1 Combination

• Supports corneal nerve healing

• Improves epithelial closure in neurotrophic keratopathy

4. NGF‑Derived Peptides

• Neurotrophic

• Support corneal nerve regeneration

5. Amniotic Membrane–Derived ECM Peptides

• Anti‑inflammatory

• Anti‑scarring

• Promote limbal stem cell support

These peptides — whether delivered naturally through biologic eye drops or synthetically through emerging therapeutics — are shaping the future of Dry Eye Disease treatment.

Biologic Eye Drops Are Already Peptide Therapies

PRP, AS, CBS, and AM are not just “blood‑based” or “tissue‑based” treatments.

They are peptide‑rich, growth‑factor–rich, regenerative therapies.

Why This Matters for Patients

Dry Eye Disease is not just a tear‑film problem.

It is an inflammatory, neurotrophic, and regenerative problem.

Peptides address all three.

They help:

• Calm inflammation

• Support corneal nerves

• Restore epithelial integrity

• Improve tear‑film stability

• Reduce symptoms and prevent progression

And because peptides are natural, specific, and biodegradable, they offer healing without the systemic side effects of many traditional drugs.

Closing Thoughts

Peptides are not the future — they are the present.

They are already saving lives in oncology, endocrinology, and immunology.

And they are already saving eyes in Dry Eye Disease, neurotrophic keratopathy, and severe ocular surface disorders.

As research accelerates, we will see more targeted peptide eye drops, more regenerative biologics, and more personalized peptide‑based therapies.

Your eyes — and your patients’ eyes — will benefit from this revolution.

Sandra Lora Cremers, MD, FACS 

| Amino acid        | Essential?               | Key roles relevant to repair / longevity / immunity              |

|-------------------|-------------------------|------------------------------------------------------------------|

| Histidine         | Essential               | Hemoglobin, histamine, antioxidant defense                       |

| Isoleucine        | Essential (BCAA)        | Muscle repair, energy, metabolic health                          |

| Leucine           | Essential (BCAA)        | mTOR activation, protein synthesis, sarcopenia prevention        |

| Lysine            | Essential               | Collagen cross-linking, carnitine, immune function               |

| Methionine        | Essential               | Methylation (SAM), antioxidant precursor                         |

| Phenylalanine     | Essential               | Dopamine, norepinephrine, epinephrine precursor                  |

| Threonine         | Essential               | Mucin, collagen, immune proteins                                 |

| Tryptophan        | Essential               | Serotonin, melatonin, niacin precursor                           |

| Valine            | Essential (BCAA)        | Muscle metabolism, energy                                        |

| Alanine           | Non-essential           | Glucose–alanine cycle, energy                                   |

| Arginine          | Conditionally essential | Nitric oxide, wound healing, immune modulation                   |

| Asparagine        | Non-essential           | Protein synthesis, glycoproteins                                 |

| Aspartate         | Non-essential           | Urea cycle, energy                                               |

| Cysteine          | Conditionally essential | Glutathione, disulfide bonds, antioxidant defense                |

| Glutamate         | Non-essential           | Neurotransmission, nitrogen metabolism                           |

| Glutamine         | Conditionally essential | Gut barrier, immune cells, nitrogen shuttle                      |

| Glycine           | Non-essential           | Collagen, antioxidant, CNS modulation                            |

| Proline           | Non-essential           | Collagen structure, wound repair                                 |

| Serine            | Non-essential           | Phospholipids, sphingolipids, signaling                          |

| Tyrosine          | Conditionally essential | Catecholamines, thyroid hormones                                 |

| Peptide / group              | Main domain          | Key actions (simplified)                                                | Dry eye relevance?                         |

|------------------------------|----------------------|-------------------------------------------------------------------------|--------------------------------------------|

| Thymosin β4 (Tβ4)            | DED / wound healing  | Corneal epithelial migration, anti-inflammatory, anti-apoptotic        | Yes – studied in DED trials                |

| YP‑P10                       | DED                  | Synthetic anti-inflammatory peptide, under clinical trial               | Yes – investigational DED drug             |

| Substance P + IGF‑1 combo    | DED / neurotrophic   | Neurotrophic, promotes epithelial healing in NK                         | Indirect – NK and severe OSD               |

| NGF / NGF-derived peptides   | DED / neurotrophic   | Corneal nerve regeneration, epithelial support                          | Yes – especially in NK                     |

| AM ECM peptides (HC‑HA/PTX3) | DED / OSD            | Anti-inflammatory, anti-scarring, stem cell support                     | Yes – via amniotic membrane                |

| GLP‑1 analogs (e.g., semaglutide) | Longevity / metabolic | Glycemic control, weight loss, ↓ CV risk, ↓ systemic inflammation  | Indirect – systemic inflammation           |

| Growth hormone–related peptides (GHRH analogs, GH secretagogues) | Longevity (controversial) | Anabolism, body composition, possible repair; must balance cancer risk | Indirect – tissue repair vs risk           |

| BPC‑157 (experimental)       | Regenerative / gut   | Preclinical data: angiogenesis, tendon/gut healing                     | No direct DED data yet                     |

| GHK‑Cu                       | Skin / repair        | Collagen synthesis, wound healing, antioxidant                          | No direct DED data; topical skin use       |

| Food bioactive peptides (milk, soy, fish, legumes) | Cancer prevention / CV | ACE inhibition, antioxidant, anti-proliferative, immune modulation | Indirect – systemic inflammation & cancer  |

| Biologic therapy | Representative peptides / factors*             | Functional role on ocular surface                          |

|------------------|-----------------------------------------------|------------------------------------------------------------|

| PRP eye drops    | PDGF, TGF‑β, VEGF, EGF, IGF‑1, fibrin/fibronectin peptides | Epithelial healing, angiogenesis modulation, anti-apoptotic, remodeling |

| Autologous serum | EGF, TGF‑β, IGF‑1, albumin-bound small peptides, fibronectin fragments | Tear-film mimicry, epithelial nutrition, moderate anti-inflammatory |

| CBS eye drops    | EGF, TGF‑β, NGF, BDNF, IGF‑1, neurotrophic peptides       | Neurotrophic support, epithelial healing, pediatric-friendly severe DED use |

| Amniotic membrane| ECM-derived collagen/laminin peptides, HC‑HA/PTX3 complex | Anti-inflammatory, anti-fibrotic, stem-cell niche support  |

1. Metheetrairut C, Ngowyutagon P, Tunganuntarat A, Khowawisetsut L, Kittisares K, Prabhasawat P. Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease. Sci Rep. 2020;10(1):15445. doi:10.1038/s41598-020-72490-2.  

2. Moleiro AF, Meraylo-Lloves J, Kim LA, et al. Blood Derivatives in Ophthalmology. EyeWiki. American Academy of Ophthalmology; updated 2023.  

3. Madan M. Platelet-Rich Plasma Eye Drops for Dry Eye Disease: Separating the Myths from the Facts. Review of Optometry. November/December 2021.  

4. ECI Therapeutics. Platelet-rich plasma-derived growth factor eye drops (ECI-101 and ECI-102) – ophthalmic products pipeline description. ECI Therapeutics website.  

5. Sosne G, et al. Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled Phase II trial. (Phase II DED trial; journal and year as listed in PubMed).  

6. Yu R, et al. Peptide therapeutics are being introduced into ophthalmology. (Review including YP‑P10; journal and year as listed in PubMed).  

7. La Manna S, et al. Peptides as therapeutic agents for inflammatory-related diseases. Int J Mol Sci. (Full citation as listed in PubMed).  

8. Wang L, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. (Full citation as listed in PubMed).  

9. Ghadiri N, et al. Bioactive peptides: an alternative therapeutic approach for cancer management. Int J Mol Sci. (Full citation as listed in PubMed).  

10. Hamdia M, et al. Bioactive peptides with potential anticancer properties from various food protein sources. (Full citation as listed in PubMed).